Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 4,000 shares at $74.10 ($297K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($297k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.10 | 3,801 | $282K | 95.0% |
| 2 | $74.82 | 199 | $15K | 5.0% |
| Total | $74.13 avg | 4,000 | $297K | 100% |
| Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |
| DXCM | SELL | 2025-06-18 | $457K | — | Filing → |